dn 1417 has been researched along with gastrin-releasing peptide in 1 studies
| Studies (dn 1417) | Trials (dn 1417) | Recent Studies (post-2010) (dn 1417) | Studies (gastrin-releasing peptide) | Trials (gastrin-releasing peptide) | Recent Studies (post-2010) (gastrin-releasing peptide) |
|---|---|---|---|---|---|
| 94 | 2 | 0 | 1,392 | 18 | 252 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imura, H; Kabayama, Y; Kato, Y; Shimatsu, A; Yanaihara, N | 1 |
1 other study(ies) available for dn 1417 and gastrin-releasing peptide
| Article | Year |
|---|---|
Stimulation by gastrin-releasing peptide, neurotensin and DN1417, a novel TRH analog, of dopamine and norepinephrine release from perifused rat hypothalamic fragments in vitro.
Topics: Animals; Dopamine; Gastrin-Releasing Peptide; Hypothalamus; Injections, Intraventricular; Male; Neurotensin; Norepinephrine; Peptides; Perfusion; Prolactin; Rats; Rats, Inbred Strains; Thyrotropin-Releasing Hormone | 1986 |